Corona Giovanni, Bianchini Silvia, Sforza Alessandra, Vignozzi Linda, Maggi Mario
Endocrinology Unit, Maggiore-Bellaria Hospital, Medical Department, Azienda-Usl Bologna, Bologna, Italy.
Sexual Medicine and Andrology Unit, Department of Experimental, Clinical and Biomedical Sciences, University of Florence, Florence; Italy.
Hormones (Athens). 2015 Oct-Dec;14(4):569-78. doi: 10.14310/horm.2002.1635.
There is evidence demonstrating that sexual complaints represent the most specific symptoms associated with late onset hypogonadism, while central obesity is the most specific sign. In obese men, hypogonadism can further worsen the metabolic profile and increase abdominal fat. In addition, although hypogonadism can exacerbate obesity-associated erectile dysfunction (ED), recent data suggest that a direct contribution of fat-derived factors could be hypothesized. In particular, an animal model recently documented that fat accumulation induces several hepatic pro-inflammatory genes closely linked to corpora cavernosa endothelial dysfunction. Lifestyle modifications and weight loss are the first steps in the treatment of ED patients with obesity or metabolic diseases. In symptomatic hypogonadal men with metabolic impairment and obesity, combining the effect of testosterone substitution with lifestyle modifications could result in better outcomes.
有证据表明,性方面的主诉是与迟发性性腺功能减退相关的最具特异性的症状,而中心性肥胖是最具特异性的体征。在肥胖男性中,性腺功能减退会进一步恶化代谢状况并增加腹部脂肪。此外,虽然性腺功能减退会加剧与肥胖相关的勃起功能障碍(ED),但最近的数据表明,可以推测脂肪衍生因子有直接作用。特别是,最近一个动物模型记录到脂肪堆积会诱导几个与海绵体内皮功能障碍密切相关的肝脏促炎基因。生活方式的改变和体重减轻是肥胖或代谢疾病的ED患者治疗的第一步。在有症状的性腺功能减退且有代谢损害和肥胖的男性中,将睾酮替代疗法的效果与生活方式的改变相结合可能会产生更好的结果。